Medical News

RSS

Medicago, IDRI to present Phase I clinical results of H5N1 vaccine at World Vaccine Congress

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that they will be presenting positive interim Phase I clinical results for their H5N1 Avian Influenza VLP vaccine candidate "H5N1 vaccine" at the World Vaccine Congress.

9 Apr 2013

University of Leicester to launch new research centre to explore complex traits and disease

This week, the University of Leicester launches a new Centre for Genetic Architecture of Complex Traits to explore the building blocks of complex traits and disease.

9 Apr 2013

First Edition: April 9, 2013

Today's headlines include reports about about various elements of the health law and how they are being viewed as implementation rolls ahead.

9 Apr 2013

Patients with psoriasis carry increased risk of developing severe co-morbid conditions

The International Federation of Psoriasis Associations, IFPA, commends the World Health Organization for raising awareness of the risks associated with high blood pressure and calls for healthcare professionals to regularly scan for the condition in patients with psoriasis.

9 Apr 2013

BEAMing technology detects more mutations linked with secondary drug resistance in GIST patients

A study presented at the AACR Annual Meeting 2013 indicates that a DNA blood test using Inostics' BEAMing Digital PCR can detect more mutations associated with secondary drug resistance in GIST patients than testing conventional biopsies.

9 Apr 2013

Quest PharmaTech to develop, market anti-PSA IgE technology for cancer treatment

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has recently signed an exclusive license agreement with University of California at Los Angeles to develop and market anti-PSA IgE technology for the treatment of cancer.

9 Apr 2013

GSK, A*STAR's ICES to develop new evidence based formulations for emerging markets

GlaxoSmithKline and A*STAR's Institute of Chemical and Engineering Sciences have signed a five-year strategic agreement to develop new evidence based formulations specifically for emerging markets.

9 Apr 2013

Tele-anesthesia can make OR care more efficient

A study exploring patterns of messages to anesthesiologists supervising care in operating rooms provides clues as to how hospitals might use "tele-anesthesia" technology to deploy anesthesia expertise and resources more efficiently, reports the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

9 Apr 2013

Exosome profiling of mRNAs and miRNAs in serum samples presented at AACR meeting

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostics for use in personalized medicine, today announced that the company is presenting a late-breaking abstract at the AACR Annual Meeting 2013, in Washington D.C.

9 Apr 2013

Experts outline challenges, opportunities of using social media in clinical care setting

As social media drastically alters the world we live in, physicians are left wondering what their role is in the digital revolution. In the first comprehensive review of its kind, experts at the George Washington University School of Medicine and Health Sciences have outlined the challenges and opportunities of using social media in a clinical care setting.

9 Apr 2013

Researchers explore how blocking EGFR changes signaling in glioblastoma cells

Proteins that control cell growth are often mutated in cancer, and their aberrant signaling drives the wild proliferation of cells that gives rise to tumors. One such protein, the epidermal growth factor receptor, fuels a wide variety of cancers-including a highly malignant brain cancer known as glioblastoma.

9 Apr 2013

Research offers new understanding related to effects of chemical conjugation on stability of ADCs

Wolfe Laboratories today announced the presentation of an abstract related to its research efforts surrounding antibody-drug conjugates at the 245th National Meeting of the American Chemical Society, held April 7-11 in New Orleans.

9 Apr 2013

Research finding provides support for lip-smacking origins of speech

The vocal lip-smacks that geladas use in friendly encounters have surprising similarities to human speech, according to a study reported in the Cell Press journal Current Biology on April 8th.

9 Apr 2013

New Japan-driven initiative to accelerate research, development innovation for neglected diseases

The Drugs for Neglected Diseases initiative, based in Geneva, Switzerland, and DNDi Japan, based in Tokyo, welcome the launch of the Global Health Innovative Technology Fund, an initiative supported by the Japanese government, several Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation.

9 Apr 2013

Blogs, opinion pieces recognize 1,000 day milestone until end of MDGs

April 5 marked 1,000 days until the end of the Millennium Development Goals, agreed to by the U.N. in 2000 as the world's first development agenda. International discussions are underway to determine the post-2015 development agenda.

9 Apr 2013

Mammalian target of rapamycin (mTOR) pathway: an interview with Dr. Paul Mischel, Ludwig Institute for Cancer Research

The mammalian target of rapamycin, mTOR is a central integrator of the cell that coordinates growth factor receptor signaling with energy and nutrient status to control a wide array of activities, including the regulation of cellular proliferation and survival.

9 Apr 2013

MD Anderson professor to receive award for clinical research excellence at AACR meeting

Hagop Kantarjian, M.D., chair and professor in The University of Texas MD Anderson Cancer Center's Department of Leukemia, will be honored for clinical research excellence at the AACR Annual Meeting 2013, April 6-10.

9 Apr 2013

Research findings could help develop effective vaccines against new strains of bird flu

Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals.

9 Apr 2013

Hebrew University professor wins 2013 Award for Outstanding Achievement in Chemistry in Cancer Research

The American Association for Cancer Research has chosen Prof. Alexander Levitzki of the Hebrew University of Jerusalem as the winner of its 2013 Award for Outstanding Achievement in Chemistry in Cancer Research.

9 Apr 2013

Cuts to NIH 'inconsistent' with university interest in global health research

"As the debate over federal budget allocations and cuts continues, the National Institutes of Health, a leading funder for both domestic and global health research, could experience a whopping $1 billion budget cut," Karen Siegel and colleagues from Emory University write in the Health Affairs Blog.

9 Apr 2013

Medical News

Medicago, IDRI to present Phase I clinical results of H5N1 vaccine at World Vaccine Congress

University of Leicester to launch new research centre to explore complex traits and disease

First Edition: April 9, 2013

Patients with psoriasis carry increased risk of developing severe co-morbid conditions

BEAMing technology detects more mutations linked with secondary drug resistance in GIST patients

Quest PharmaTech to develop, market anti-PSA IgE technology for cancer treatment

GSK, A*STAR's ICES to develop new evidence based formulations for emerging markets

Tele-anesthesia can make OR care more efficient

Exosome profiling of mRNAs and miRNAs in serum samples presented at AACR meeting

Experts outline challenges, opportunities of using social media in clinical care setting

Researchers explore how blocking EGFR changes signaling in glioblastoma cells

Research offers new understanding related to effects of chemical conjugation on stability of ADCs

Research finding provides support for lip-smacking origins of speech

New Japan-driven initiative to accelerate research, development innovation for neglected diseases

Blogs, opinion pieces recognize 1,000 day milestone until end of MDGs

Mammalian target of rapamycin (mTOR) pathway: an interview with Dr. Paul Mischel, Ludwig Institute for Cancer Research

MD Anderson professor to receive award for clinical research excellence at AACR meeting

Research findings could help develop effective vaccines against new strains of bird flu

Hebrew University professor wins 2013 Award for Outstanding Achievement in Chemistry in Cancer Research

Cuts to NIH 'inconsistent' with university interest in global health research

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News